Geno Focus Inc. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
2,404
6,148
6,640
7,029
11,506
Cost of Goods Sold (COGS) incl. D&A
1,235
3,666
4,373
4,121
8,321
Gross Income
1,169
2,482
2,267
2,907
3,185
SG&A Expense
922
1,076
1,114
1,566
1,978
EBIT
244
1,392
1,098
1,341
1,207
Unusual Expense
-
-
-
-
468
Non Operating Income/Expense
7
37
126
77
210
Interest Expense
100
154
19
-
103
Pretax Income
158
1,370
1,317
1,566
1,198
Income Tax
11
811
105
49
145
Consolidated Net Income
147
2,182
1,211
1,615
1,343
Net Income
147
2,182
1,211
1,615
1,411
Net Income After Extraordinaries
147
2,182
1,211
1,615
1,411
Net Income Available to Common
147
2,182
1,211
1,615
1,411
EPS (Basic)
9.97
148.28
80.50
73.00
65.00
Basic Shares Outstanding
15
15
15
22
22
EPS (Diluted)
9.97
148.28
71.98
70.65
63.34
Diluted Shares Outstanding
15
15
17
23
22
EBITDA
324
1,484
1,248
1,698
2,437
Other Operating Expense
4
14
55
-
-
Non-Operating Interest Income
22
95
112
148
772
Minority Interest Expense
-
-
-
-
68

About Geno Focus

View Profile
Address
Unit 201, Migun Techno World II
Daejeon DE 34014
Korea, Republic Of
Employees -
Website http://www.genofocus.com
Updated 09/14/2018
GenoFocus, Inc. engages the research and development of technologies related to biochemical and biotechnology industry. Its products include enzymes for food, animal, bioconversion and edible vaccines. In addition, It also provides technical services such as library generation, high-throughput screening and consulting services.